A. E. Eskazan And D. Keskin, "Radotinib and its clinical potential in chronic-phase chronic myeloid leukemia patients: an update.," Therapeutic advances in hematology , vol.8, pp.237-243, 2017
Eskazan, A. E. And Keskin, D. 2017. Radotinib and its clinical potential in chronic-phase chronic myeloid leukemia patients: an update.. Therapeutic advances in hematology , vol.8 , 237-243.
Eskazan, A. E., & Keskin, D., (2017). Radotinib and its clinical potential in chronic-phase chronic myeloid leukemia patients: an update.. Therapeutic advances in hematology , vol.8, 237-243.
Eskazan, Ahmet, And Dilek KESKİN. "Radotinib and its clinical potential in chronic-phase chronic myeloid leukemia patients: an update.," Therapeutic advances in hematology , vol.8, 237-243, 2017
Eskazan, Ahmet E. And Keskin, Dilek. "Radotinib and its clinical potential in chronic-phase chronic myeloid leukemia patients: an update.." Therapeutic advances in hematology , vol.8, pp.237-243, 2017
Eskazan, A. E. And Keskin, D. (2017) . "Radotinib and its clinical potential in chronic-phase chronic myeloid leukemia patients: an update.." Therapeutic advances in hematology , vol.8, pp.237-243.
@article{article, author={Ahmet Emre EŞKAZAN And author={Dilek KESKİN}, title={Radotinib and its clinical potential in chronic-phase chronic myeloid leukemia patients: an update.}, journal={Therapeutic advances in hematology}, year=2017, pages={237-243} }